Skip to main content
Back
SNNUF logo

Smith & Nephew plc

Data quality: 100%
SNNUF
OTC Healthcare Medical - Devices
$16.50
$0.00 (0.00%)
Mkt Cap: 14.01B
Also listed as SNN NYSE
Day Range
$16.05 $16.50
52-Week Range
$12.55 $18.50
Volume
2,700
50D / 200D Avg
$17.02 / $16.45
Prev Close
$16.05

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (627 peers)

Metric Stock Sector Median
P/E 21.9 0.4
P/B 2.6 2.9
ROE % 12.1 3.9
Net Margin % 10.1 3.8
Rev Growth 5Y % 4.9 10.0
D/E 0.6 0.2

Key Takeaways

Revenue grew 4.86% annually over 5 years — modest growth
Earnings grew 55.07% over the past year
ROE of 12.10% — decent returns on equity
Generating 870.95M in free cash flow
PEG of 0.39 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.59%

Growth

Revenue Growth (5Y)
4.86%
Revenue (1Y)8.45%
Earnings (1Y)55.07%
FCF Growth (3Y)119.36%

Quality

Return on Equity
12.10%
ROIC8.91%
Net Margin10.14%
Op. Margin16.27%

Safety

Debt / Equity
0.63
Current Ratio2.57
Interest Coverage6.43

Valuation

P/E Ratio
21.93
P/B Ratio2.64
EV/EBITDA16.37
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 8.45% Revenue Growth (3Y) 6.56%
Earnings Growth (1Y) 55.07% Earnings Growth (3Y) 55.86%
Revenue Growth (5Y) 4.86% Earnings Growth (5Y) 5.08%
Profitability
Revenue (TTM) 6.30B Net Income (TTM) 638.90M
ROE 12.10% ROA 6.10%
Gross Margin 68.01% Operating Margin 16.27%
Net Margin 10.14% Free Cash Flow (TTM) 870.95M
ROIC 8.91% FCF Growth (3Y) 119.36%
Safety
Debt / Equity 0.63 Current Ratio 2.57
Interest Coverage 6.43 Dividend Yield 0.02%
Valuation
P/E Ratio 21.93 P/B Ratio 2.64
P/S Ratio 2.22 PEG Ratio 0.39
EV/EBITDA 16.37 Dividend Yield 0.02%
Market Cap 14.01B Enterprise Value 16.78B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 6.30B 5.81B 5.55B 5.22B 5.21B
Net Income 638.90M 412.00M 263.00M 223.00M 524.00M
EPS (Diluted) 0.73 0.47 0.30 0.26 0.59
Gross Profit 4.29B 4.05B 3.82B 3.68B 3.67B
Operating Income 1.03B 657.00M 425.00M 450.00M 593.00M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 10.47B 10.35B 9.99B 9.97B 10.92B
Total Liabilities 5.18B 5.09B 4.77B 4.71B 5.35B
Shareholders' Equity 5.30B 5.27B 5.22B 5.26B 5.57B
Total Debt 3.33B 3.32B 3.08B 2.87B 3.34B
Cash & Equivalents 557.89M 619.00M 302.00M 350.00M 1.29B
Current Assets 4.11B 4.42B 4.03B 3.86B 4.42B
Current Liabilities 1.60B 1.53B 2.27B 1.72B 2.13B

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#631 of 1052
39
Growth + Value Growth at a Reasonable Price (Peter Lynch)
#107 of 332
59

Recent Activity

Entered Cash Flow Compounder
Mar 24, 2026
Entered Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026